| Literature DB >> 32200439 |
Sara Cheleschi1,2, Ines Gallo3, Sara Tenti3.
Abstract
Balneotherapy (BT) is one of the most commonly used complementary therapies for many pathological conditions. Its beneficial effects are related to physical and chemical factors, but the exact mechanism of action is not fully understood. Recently, there has been an increased interest in the use of preclinical models to investigate the influence of BT on inflammation, immunity, and cartilage and bone metabolism. The objective of this comprehensive analysis was to summarize the current knowledge about the in vitro studies in BT and to revise the obtained results on the biological effects of mineral waters. Special attention has been paid to the main rheumatological and dermatological conditions, and to the regulation of the immune response. The objective of this review was to summarize the in vitro studies, on human and animal samples, investigating the biological effects of BT. In particular, we analyzed the properties of a thermal water, as a whole, of an inorganic molecule, such as hydrogen sulfide in different cell cultures (keratinocytes, synoviocytes, chondrocytes, and peripheral blood cells), or of the organic component. The results corroborated the scientific value of in vitro studies in demonstrating the anti-inflammatory, antioxidant, chondroprotective, and immunosuppressive role of BT at the cellular level. However, the validity of the cell culture model is limited by several sources of bias, as the differences in experimental procedures, the high heterogeneity among the available researches, and the difficulties in considering all the chemical and physical factors of BT. We would like to stimulate the scientific community to standardize the experimental procedures and enhance in vitro research in the field of BT.Entities:
Keywords: Balneotherapy; Cell cultures; Chondrocytes; Hydrogen sulfide; Keratinocytes; Mineral waters
Mesh:
Substances:
Year: 2020 PMID: 32200439 PMCID: PMC7223834 DOI: 10.1007/s00484-020-01890-4
Source DB: PubMed Journal: Int J Biometeorol ISSN: 0020-7128 Impact factor: 3.787
In vitro studies on human samples evaluating the beneficial effects of BT on skin diseases
| Authors | Treatment(s) | Experimental model | Mineral water or inorganic or organic components | Pathology | Biochemical parameters | Results |
|---|---|---|---|---|---|---|
| (Gobbi et al. | 30-min preincubation with MAPK/ERK inhibitors (10–30 μM) + NaHS (400 mM) dissolved in the culture medium, for 6, 12, 18, 24 h | Normal skin–derived immortalized human keratinocytes | NaHS | Psoriasis | IL-8, IL-17, IL-22; cell proliferation and adhesion; MAPK/ERK signaling phosphorylation | Reduced IL-8, IL-17, IL-22 secretion, adhesion molecules expression, and MAPK/ERK phosphorylation Reduction of inflammation events typical of psoriatic lesions |
| (Mirandola et al. | 30-min preincubation with MAPK/ERK inhibitors (10–30 μM) + NaHS (400 mM) dissolved in the culture medium, for 6, 12, 18, 24 h | Normal skin-derived immortalized human keratinocytes | NaHS | Psoriasis | IL-8; MAPK/ERK signaling phosphorylation | Reduced basal and IL-17/IL-22-induced IL-8 expression and secretion; Reduced MAPK/ERK phosphorylation Reduction of inflammation events typical of psoriatic lesions |
| (Chiarini et al. | 25%, 50%, or 100% of Comano water dissolved in the culture medium, for 11 days | Human primary epidermal keratinocytes | Comano spa’s water (Trentino, Italy), rich in sodium, calcium and bicarbonate | Psoriasis | VEGF-A | Reduced VEGF-A expression and secretion Reduction of VEGF-A-mediated angiogenic, vessel permeabilizing, and chemotactic effects |
| (Chiarini et al. | 25%, 50%, or 100% of Comano water dissolved in the culture medium, from 3 to 15 days | Human primary epidermal keratinocytes | Comano spa’s water (Trentino, Italy), rich in sodium, calcium and bicarbonate | Psoriasis | IL-6, CK-16, VEGF-A | Reduced IL-6, VEGF, and CK-16 release and expression Reduction of inflammation, and neo-angiogenic phenomena of local psoriatic manifestations |
| (Dal Pra et al. | 25%, 50%, or 100% of Comano water dissolved in the culture medium, from 11 to 13 days | Human primary epidermal keratinocytes | Comano spa’s water (Trentino, Italy), rich in sodium, calcium and bicarbonate | Psoriasis | IL-8, TNF-α | Reduced IL-8 and TNF-α intracellular levels and secretion rates Reduction of inflammation events typical of psoriatic lesions |
| (Lee et al. | 50% of Yong-gung oncheon thermal spring water dissolved in the culture medium, for 1, 4, 10, and 24 h + LPS (10 μL/mL) | Human keratinocyte cell lines, HaCaT | Thermal spring water (Yong-gung oncheon, Ganghwa-gun, Korea), rich in sulfur, magnesium, calcium and selenium | Skin disease | IL-6, IL-8; CD4+ T cells differentiation | Reduced IL-6 and IL-8 gene and protein expression; attenuated differentiation of CD4+ T cells in Th1, Th2 and Th17 Attenuation of immune skin reactions |
| (Karagülle et al. | 10% of Bursa and Bolu thermal mineral waters dissolved in the culture medium, for 3 days | Human keratinocyte cell lines, HaCaT | Bursa and Bolu thermal mineral waters (Turkey), rich in silicium, zinc, sodium bicarbonate, and boron | Psoriasis and rosacea | IL-1α, TNF-α, and VEGF | Reduced IL-1α, TNF-α, and VEGF gene expression Reduction of inflammation, and neo-angiogenic phenomena of skin disease manifestations |
| (Gerencsér et al. | Organic fraction of Hungarian Kakasszék and Gyopáros Spa waters dissolved in the culture medium for 1 h + UV exposure of 10, 20, 30, 40 and 50 s | Human keratinocyte cell lines, HaCaT | organic-rich extract of Hungarian Kakasszék (65 mg/L) and Gyopáros Spa waters (14 mg/L) (Hungary) | Skin disease | DNA fragmentation rate | Reduced DNA lesions Prevention of adverse effects of solar or artificial UV radiation on the human skin |
MAPK mitogen-activated protein kinase, ERK extracellular signal–regulated kinase, NaHS natrium hydrogen sulfide, IL interleukin, VEGF-A vascular endothelial growth factor A, CK-16 cytokeratin 16, TNF-α tumor necrosis factor α, LPS lipopolysaccharide, HaCaT human keratinocyte cell lines, CD4+cluster of differentiation 4, Th T helper cells
In vitro studies on human and animal samples evaluating the beneficial effects of BT on joint disorders
| Authors | Treatment(s) | Experimental model | Mineral water or inorganic or organic components | Pathology | Biochemical parameters | Results |
|---|---|---|---|---|---|---|
| (Kloesch et al. | NaHS (0.030–1.0 mM) dissolved in the culture medium, for 1, 3, 6, 12 h + IL-1β (5 ng/mL) for 1 h | RA human fibroblast-like synoviocytes | NaHS | Rheumatoid Arthritis | IL-6; P38/MAPK/ERK signaling activation/deactivation | Reduced IL-6 expression and activation of MAPK/ERK signaling (low NaHS concentrations) Increased IL-6 expression and activation of MAPK/ERK signaling (high NaHS concentrations) Reduction of inflammatory events of RA |
| (Kloesch et al. | NaHS (1.0 mM) dissolved in the culture medium, for 1, 3, 6, 12 h | RA and OA human fibroblast-like synoviocytes | NaHS | Rheumatoid Arthritis and Osteoarthritis | IL-6, IL-8, COX-2; MMP-2, MMP-3, MMP-14; P38/MAPK/ERK protein expression | Increased IL-6, IL-8, COX-2 and p38/MAPK/ERK expression Increase of inflammatory events of RA and OA |
| (Kloesch et al. | NaHS (0.125 and 1.0 mM) dissolved in the culture medium, for 15, 30, 45 and 60 min + MAPK inhibitors (1 and 5 μM) + IL-1β (5 ng/mL) for 1 h | Human chondrocyte cell line (C-28/I2) | NaHS | Rheumatoid Arthritis | IL-6, IL-8; P38/MAPK/ERK and NF-kB signaling activation/deactivation | Reduced IL-6 and IL-8 expression and activation of p38/MAPK/ERK and NF-kB signaling Reduction of inflammatory processes of arthritis |
| (Fox et al. | IL-1β, IL-6 and TNF-α (5 ng/mL) for 6, 12 and 18 h + GYY4137 (50–500 mol/L) dissolved in the culture medium, for 12 h | Human primary articular chondrocytes | GYY4137 | Rheumatoid Arthritis | Cell death; Mitochondrial membrane potential | Reduced cell death and oxidant-induced mitochondrial dysfunction Limitation of inflammation in chronic inflammatory diseases |
| (Li et al. | GYY4137 (0.1–0.5 mM) dissolved in the culture medium, for 18 h + LPS (10 μg/mL) | Human primary arthritis synoviocytes and chondrocytes | GYY4137 | Rheumatoid arthritis | IL-6, TNF-α, PGE2, COX-2; NO, iNOS; NF-kB signaling activation/deactivation | Reduced IL-6, TNF-α, PGE2 and NO production, COX-2 and iNOS catalytic activity, and NF-kB activation Reduction of inflammatory processes of arthritis |
| (Burguera et al. | NaHS and GYY4137 (0.05–1 mM) dissolved in the culture medium, for 24 or 48 h + IL-1β (5 ng/mL) | Human primary OA chondrocytes | NaHS and GYY4137 | Osteoarthritis | IL-6, PGE2, PTGES, COX-2; NO, NOS2; MMP-13; NF-kB signaling activation | Reduced IL-6, PGE2, and NO release and protein level, IL-6, PTGES, COX-2, and NOS2 gene expression, and NF-κB nuclear translocation Reduction of inflammatory and degrading processes of OA damage |
| (Ha et al. | NaHS (0.06–1.5 mM) dissolved in the culture medium, for 24 h + IL-1β (10 ng/mL) | Human primary OA chondrocytes | NaHS | Osteoarthritis | COX-2, iNOS, MMP-13; ERK/IκBα/NF-κB signaling activation | Reduced COX-2, iNOS, MMP-13 release and gene expression; Inhibited ERK/IκBα/NF-κB activation Reduction of degrading processes of OA damage |
| (Sieghart et al. | NaHS (0.06–1 mmol/L) dissolved in the culture medium, for 1 h + IL-1β (10 ng/mL) | Human primary OA fibroblast-like synoviocytes | NaHS | Osteoarthritis | IL-6, IL-8; MMP-2, MMP-14; MAPK and Akt1/2/PI3K protein phosphorylation | Reduced IL-6 and IL-8 secretion, MMP-2 and MMP-14 gene expression, and MAPK phosphorylation; Increased Akt1/2 phosphorylation Reduction of inflammatory and degrading processes of OA damage |
| (Vela-Anero et al. | NaHS or GYY4137 (200 or 1000 μM) dissolved in the culture medium, for 21 days + IL-1β (5 ng/mL) | Human OA cartilage disks | NaHS and GYY4137 | Osteoarthritis | MMP-3, MMP-13; Col2a1, glycosaminoglycans, aggrecans | Reduced MMP-3 and MMP-13 production, and increased Col2a1, glycosaminoglycans, and aggrecans synthesis Reduction of degrading processes of OA damage |
| (Fioravanti et al. | 25%, 50%, or 100% of Vetriolo thermal water dissolved in the culture medium, for 48 h + IL-1β (5 ng/mL) | Human primary OA chondrocytes | Vetriolo thermal water (Trentino Alto Adige, Italy), strongly acidic sulfate, rich in calcium, magnesium and iron | Osteoarthritis | NO, iNOS; Cell viability and apoptosis; Morphological assessment | 25%, 50% of Vetriolo water increased survival recovery rate, reduced NO levels, iNOS expressions, and apoptosis %; Enhanced morphological characteristics Reduction of degrading processes of OA damage |
| (Xu et al. | NaHS (100 μM) dissolved in the culture medium, for 4 h + (H2O2) (400 μM) | Murine osteoblast-like cell line (MC3T3-E1) | NaHS | Osteoporosis | Viability, proliferation and apoptosis; NO, ALP, SOD, NADPH oxidase p38/ERK1/2/MAPKs activation | Increased viability, cell proliferation, ALP and SOD activities; Decreased apoptosis, NO release and NADPH oxidase activity, and p38/ERK1/2/MAPKs activation Proliferative and antioxidant effects against osteoporosis damage |
| (Gambari et al. | NaHS (50–300 μM) dissolved in the culture medium, for 72 h to 6 days | Human differentiated osteoclasts | NaHS | Osteoporosis | Osteoclasts differentiation; ROS production, NRF2, KEAP1, NQO1, and PRDX1 | Decreased osteoclast differentiation, intracellular ROS levels; Upregulated NRF2 protein expression and nuclear translocation, and increased antioxidant gene expression Antioxidant effects against osteoporosis damage |
| (Lv et al. | GYY4137 (100 μM) dissolved in the culture medium, for 4 h + (H2O2) (400 μM) | Murine osteoblast-like cell line (MC3T3-E1) | GYY4137 | Osteoporosis | Viability, proliferation, Runx2, and apoptosis; NO, ALP, and SOD ERK1/2 activation | Increased viability, cell proliferation, ALP and SOD activities, and Runx2 gene expression; Decreased apoptosis, NO release, and ERK1/2 activation Proliferative and antioxidant effects against osteoporosis damage |
| (Liu et al. | NaHS (400 μmol/L) dissolved in the culture medium, for 12 h | Rat primary osteoblasts | NaHS | Osteoporosis | Osteoblast proliferation and mineralization; Apoptosis; KATP protein expression | Decreased cell proliferation, and increased the number of apoptotic cells, osteoblast mineralization, and KATP protein expression Reduction of osteoporosis damage |
NaHS natrium hydrogen sulfide, IL interleukin, RA rheumatoid arthritis, MAPK mitogen-activated protein kinase, ERK extracellular signal-regulated kinase, OA osteoarthritis, COX-2 cyclooxygenase 2, MMP metalloproteinase, C-28/I2 human chondrocyte cell line, NF-κB nuclear factor-κB, GYY4137 exogenous slow releasing H2S, LPS lipopolysaccharide, TNF-α tumor necrosis factor α, PGE2 prostaglandin E2, NO nitric oxide, iNOS inducible NO synthase, PTGES prostaglandin E synthase, IκBα inhibitor of κB, Akt protein kinase B, PI3K phosphoinositide 3-kinase, Col2a1 collagen type II alpha 1 chain, ALP alkaline phosphatase, SOD superoxide dismutase, NADPH nicotinamide adenine dinucleotide phosphate, ROS reactive oxygen species, NRF2 nuclear factor erythroid 2-related factor 2, Keap1 Kelch-like ECH-associated protein 1, NQO1 NADPH quinone dehydrogenase 1, PRDX1 peroxiredoxin 1, HO hydrogen peroxide, MC3T3-E1 murine osteoblast-like cell line, Runx2 runt-related transcription factor 2, KATP ATP-sensitive potassium channels
In vitro studies on human and animal samples evaluating the beneficial effects of BT on immune response
| Authors | Treatment(s) | Experimental model | Mineral water or inorganic or organic components | Pathology | Biochemical parameters | Results |
|---|---|---|---|---|---|---|
| (Rinaldi et al. | NaHS (from 0.23 to 3.66 mM) dissolved in the culture medium, for 24 h + p38/MAPK inhibitors (30–60 μM) | Human purified neutrophils, eosinophils or lymphocytes | NaHS | Inflammatory processes of respiratory tract | Cell viability and apoptosis; P38/MAPK signaling activation/deactivation | Short-term survival of neutrophils delaying the onset of apoptosis Reduced caspase-3 cleavage and p38/MAPK phosphorylation in neutrophils Accelerate the resolution of inflammatory processes |
| (Mirandola et al. | NaHS (from 0.20 to 4.0 mM) dissolved in the culture medium, for 24 h + caspase inhibitors (30 μM) | Human purified peripheral blood lymphocytes | NaHS | Inflammatory processes | Cell viability and apoptosis; IL-2 | Decreased proliferation of lymphocyte subsets, CD8+ T and NK cells, and reduced IL-2 production Accelerate the resolution of inflammatory processes |
| (Sulen et al. | NaHS (10, 100 or 1000 μM) dissolved in the culture medium, for 10 min | Human peripheral blood mononuclear cells (PBMCs) | NaHS | Inflammatory processes | p38/MAPK, NF-κB p65, AKT and CREB phosphorylation | Induced p38/MAPK, AKT, and CREB phosphorylation Reduction of inflammatory processes |
| (Miller et al. | H2S (50–500 nM) dissolved in the culture medium, for 4, 10, and 24 h | Primary mouse T lymphocytes (CD3+), OT-II CD4+ T cells | H2S | Inflammatory processes of bowel diseases | CD69, CD25; IL-2; cystathionine γ-lyase, cystathionine β-synthase | Enhanced T cell activation, CD69, and IL-2 expression, and CD25 levels; Increased cystathionine γ-lyase and cystathionine β-synthase expression Reduction of inflammatory processes of bowel diseases |
| (Han et al. | NaHS (0.25, 0.5, 1, 2, 4 and 8 mM) and GYY4137 (200, 400, 800, 1600 μM) dissolved in the culture medium, for 0.5, 1, 2, 4, 6, 12, 24, 36, 48 h | Human purified peripheral blood lymphocytes | NaHS and GYY4137 | Inflammatory processes of systemic lupus erythematosus | Cell viability, cell cycle distribution; AKT (ser473), GSK3β (ser9), p27Kip1 and p21CIP1 | Increased cell proliferation and S phase distribution of cell cycle; Decreased AKT (ser473), GSK (ser9), and increased p27Kip1 and p21CIP1 expression and phosphorylation Reduction of inflammatory processes of systemic lupus erythematosus |
| (Braga et al. | Sulfurous thermal water (different concentrations) dissolved in the culture medium, for 15 min + N-formyl-methionyl-leucyl-phenylalanine/phorbol-12-myristate-13-acetate | Human purified neutrophils | Sulfurous thermal water (Acqui Terme, Piemonte, Italy), which contains different HS groups concentrations | Inflammatory processes | ROS and RNS | Reduced ROS and RNS release at 0.94 to 15.5 μg/mL of HS Reduction of inflammatory processes |
| (Braga et al. | Sulfurous water or NaHS (from 4.5 to 18 mg/mL) dissolved in the culture medium, for 15 min | Human purified neutrophils | Sulfurous thermal water (Acqui Terme, Piemonte, Italy) and NaHS | Inflammatory processes of upper and lower airway diseases | Elastase release; elastolytic activity | Inhibited elastase release Reduction of inflammatory processes |
| (Prandelli et al. | Sirmione thermal water or NaHS (2.5 mM) dissolved in the culture medium, for 24 h + LPS 100 (ng/mL) | Human primary monocytes | Sirmione thermal water (Lombardia, Italy), rich in sodium chloride, bromine and iodine | Chronic inflammatory and age-related illness | TNF-α, IL-1β, IL-6, IL-12; CXCL8, CCL5; ROS, antioxidant enzymes | NaHS reduced TNF-α, IL-1β, IL-6, IL-12, CXCL8, CCL5 production, ROS formation and antioxidant enzymes; Sirmione water enhanced IL-10 release Reduction of chronic inflammatory and age-related illness manifestations |
NaHS natrium hydrogen sulfide, MAPK mitogen-activated protein kinase, IL interleukin, NK natural killers, HS hydrogen sulfide, CD3 cluster of differentiation 3, CD4 cluster of differentiation 4, CD69 cluster of differentiation 69, CD25 interleukin-2 receptor alpha chain, GYY4137 exogenous slow releasing H2S, Akt protein kinase B, GSK3β glycogen synthase kinase-3β, p27 cyclin-dependent kinase inhibitor 1B, p21 cyclin-dependent kinase inhibitor 1, PBMCs human peripheral blood mononuclear cells, NF-κB nuclear factor-κB, CREB cAMP response element-binding protein, ROS reactive oxygen species, RNS reactive nitrogen species, LPS lipopolysaccharide, TNF-α tumor necrosis factor α, CXCL8 chemokine (C-X-C motif) ligand 8, CCL5 Chemokine (C-C motif) ligand 5